AU6761198A - Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor - Google Patents

Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor

Info

Publication number
AU6761198A
AU6761198A AU67611/98A AU6761198A AU6761198A AU 6761198 A AU6761198 A AU 6761198A AU 67611/98 A AU67611/98 A AU 67611/98A AU 6761198 A AU6761198 A AU 6761198A AU 6761198 A AU6761198 A AU 6761198A
Authority
AU
Australia
Prior art keywords
ddi
hydroxyurea
protease inhibitor
hiv combination
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67611/98A
Inventor
Julianna Lisziwiewicz
Franco Lori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6761198A publication Critical patent/AU6761198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU67611/98A 1998-03-17 1998-03-17 Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor Abandoned AU6761198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/005092 WO1999047146A1 (en) 1998-03-17 1998-03-17 Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor

Publications (1)

Publication Number Publication Date
AU6761198A true AU6761198A (en) 1999-10-11

Family

ID=22266598

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67611/98A Abandoned AU6761198A (en) 1998-03-17 1998-03-17 Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor

Country Status (2)

Country Link
AU (1) AU6761198A (en)
WO (1) WO1999047146A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004251228B2 (en) * 2003-05-16 2008-04-24 University Of Maryland Biotechnology Institute Compositions for down-regulation of CCR5 expression and methods of use therefor
WO2018208826A1 (en) * 2017-05-08 2018-11-15 Meharry Medical College Hydroxyurea to enhance sperm cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094310A (en) * 1992-12-15 1994-11-02 托马斯·C·梅里根 Combination chemotherapy for HIV infections
ATE273700T1 (en) * 1993-05-21 2004-09-15 Us Gov Health & Human Serv NEW METHOD FOR INHIBITING THE REPLICATION OF THE VIRUS-DEPENDENT REVERSE TRANSCIPTASE BY USING DIDEOXYDENUCLEOTIDE SYNTHESIS INHIBITORS
US6689761B1 (en) * 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
EP0882134B8 (en) * 1996-02-21 2009-09-02 Genetic Immunity kft. Methods and compositions for protective and therapeutic genetic immunization

Also Published As

Publication number Publication date
WO1999047146A1 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
NZ329626A (en) 1-phenylthio-2-benzamido-3-hydroxy-4-piperidino-butane, hiv protease inhibitors
AU2001247782A1 (en) 18221, dual specificity phosphatase and uses thereof
AU1579000A (en) Cleansing assembly comprising a grip and one or more cleansing elements
AU4723799A (en) Protease inhibitors
AU7139598A (en) Protease inhibitors
AU4092799A (en) Protease inhibitors
EP0691345A3 (en) HIV protease inhibitor combinations
AUPM982594A0 (en) HIV protease inhibitors
AU9110298A (en) Protease inhibitors
AU7457996A (en) Cystatin m, a novel cysteine proteinase inhibitor
AU4229599A (en) Protease inhibitor peptides
AU7476900A (en) 26176, a novel calpain protease and uses thereof
AU7133898A (en) Nanosized aspartyl protease inhibitors
AU2713100A (en) Protease inhibitors
AU9300298A (en) Protease inhibitors
AU7624300A (en) 23484, a human ubiquitin protease
ZA984514B (en) Hiv protease inhibitor
AU1071901A (en) 23431, a novel human ubiquitin protease
AU6761198A (en) Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
AU1904599A (en) Hiv/fiv protease inhibitors having a small p3 residue
AU3519299A (en) Human casb12 polypeptide, a serine protease
AU7689798A (en) Vif-derived hiv protease inhibitors
AU2001270603A1 (en) Calpain protease 12
AU2001241770A1 (en) 18036, a novel calpain-like protease and uses thereof
AU2001239897A1 (en) 18232, a dual specificity phosphatase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase